Ask whether the test has been validated against in-person exams for Parkinson's patients specifically, what device and internet connection it requires, and what happens if a motor symptom like tremor affects your performance. Remote cognitive testing has moved from a pandemic workaround to a standard option in several active Parkinson's studies, but not every tool has been checked against the gold-standard clinic visit in the same way. Knowing which questions to raise before you agree to a video call, phone interview, or self-administered online screen can save you a frustrating session and give the research team better data. The answers below walk through what's been tested, where remote testing still falls short, and what to confirm with study staff before your appointment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How Accurate Is Remote Testing Compared to an In-Person Exam?
- What Tool or Platform Will the Study Actually Use?
- Video Call, Phone, or Self-Administered — Which Will You Get?
- What Should You Ask Before Your Session?
- What Limitations Are Researchers Still Working Through?
- Frequently Asked Questions
How Accurate Is Remote Testing Compared to an In-Person Exam?
Accuracy varies by which test is used and how it's delivered. A University of Pennsylvania pilot of 35 Parkinson's patients found that only three measures — the Dementia Rating Scale-2, Trail Making Test A, and phonemic verbal fluency — showed good agreement between virtual and in-person administration, while semantic verbal fluency scores ran significantly higher when given remotely, according to a study published on PMC. That mismatch matters because a single test score can factor into treatment decisions or trial eligibility. If your study relies on verbal fluency tasks, ask whether the research team adjusts for the virtual-format difference or uses a separate scoring norm for remote sessions.
Other tools have held up better. The Montreal Cognitive Assessment (MoCA), a widely used 30-point screening tool for memory and thinking skills, tracked the same patterns by video conference as it did in person across Parkinson's patients, cerebellar ataxia patients, and healthy controls, in both English and Hebrew, per research in Frontiers in Human Neuroscience. Ask the study coordinator which specific test is being used and whether it's one with published remote-validation data for Parkinson's patients. A broader 2026 analysis benchmarking remote measures against the Parkinson's Progression Markers Initiative's in-person dataset of 1,417 participants concluded that it's still unclear whether remote cognitive measures track disease severity as reliably as in-clinic testing, according to Frontiers in Aging Neuroscience. That uncertainty is a reasonable thing to raise directly with the research team rather than assume has been settled.
What Tool or Platform Will the Study Actually Use?
Ask for the name of the specific instrument, not just "a cognitive test." Options researchers are currently using or developing for Parkinson's studies differ in format and purpose. ORCA-PD is a 15-minute self-administered online screen designed specifically to avoid drawing and motor tasks that can be thrown off by Parkinson's-related tremor or slowness, and it was tested in 112 Parkinson's participants with a 93% completion rate. Cambridge Cognition's CANTAB computerized battery is being used in the Michael J. Fox Foundation's Parkinson's Progression Markers Initiative, with a plan to run roughly 5,000 assessments to characterize participants' cognition across that study.
If your study is affiliated with that initiative, CANTAB may be the tool involved. Ask whether the tool has been checked against your Parkinson's symptoms specifically. ORCA-PD's scores distinguished Parkinson's patients from neurotypical controls and separated patients with mild cognitive impairment from those without, which supports its use as a screening tool rather than a full diagnostic exam. A screening tool flagging a concern typically leads to follow-up testing, not a standalone diagnosis — ask the coordinator what happens after a flagged result.
Video Call, Phone, or Self-Administered — Which Will You Get?
The format changes what you'll need and how the session will feel. A clinician-led video visit means a Parkinson's specialist conducts a neurological exam and cognitive test over video conference in your own home; the Michael J. Fox Foundation's Virtual Research Visits pilot ran this model across participants in four states and reported 93% participant satisfaction. Self-administered online batteries work differently — you complete the test alone, often across two separate sessions, with no clinician present during the testing itself.
A medRxiv-reported study had 67 Parkinson's patients and 36 older adults complete a fully unsupervised at-home battery this way to check feasibility and consistency between the two sessions, a distinct approach from video-proctored testing. Phone-only testing is a third option, usually chosen when video isn't practical. In the COPE-PAP trial, which studied sleep apnea treatment in Parkinson's patients with MoCA scores of 27 or below, researchers substituted telephone-administered neurocognitive testing for in-person assessment at the 3- and 6-month marks, a change made as a pandemic-driven protocol adjustment according to the study published in Trials journal. Ask which of these three formats applies to you, since each has different requirements for equipment, privacy, and whether someone can assist you during the session.
📨 Get Free Parkinson's Guides Alerts
Free · No spam · Unsubscribe anytime
What Should You Ask Before Your Session?
A short list of practical questions can head off problems on test day: If the study enrolled you with a MoCA score at a certain threshold, as COPE-PAP did with scores of 27 or below, ask whether your remote results will be compared against that same cutoff or handled differently.
- Which specific test or battery will be used, and has it been validated for Parkinson's patients remotely?
- Is the session live with a clinician, or will you complete it alone on a device?
- What device, browser, or app is required, and is a practice run offered beforehand?
- Can a caregiver or family member be in the room, and does that affect scoring?
- What happens if your internet connection drops or a motor symptom interferes mid-test?
What Limitations Are Researchers Still Working Through?
Remote cognitive testing in Parkinson's research is active but not fully settled. The enrollment pace of ongoing validation work shows how much is still underway: the Michael J. Fox Foundation's "Online Motor and Cognitive Analysis System" grant, which validates internet-based motor and cognitive tests against standard in-person clinical scores, reported 50 of a planned 100 patients enrolled as of its most recent progress update.
The core open question is whether remote scores track disease progression as reliably as clinic visits do, which the 2026 Frontiers in Aging Neuroscience analysis against the PPMI's 1,417-participant dataset left unresolved. That doesn't mean remote testing is unreliable — several individual tools, including the MoCA by video and the ORCA-PD screen, have shown strong agreement with in-person results in their own studies. It means the field hasn't yet established one standard that applies across every test and every delivery method. Given that, it's reasonable to ask your study team whether results from your remote session will ever be reconciled with an in-person visit, either within this study or a future one, and whether your data will be flagged differently if your test format changes partway through your participation.
Frequently Asked Questions
Can a caregiver help during a remote cognitive test?
This depends on the specific study and test; ask the coordinator directly, since some self-administered batteries require you to complete the session alone to keep scoring comparable across participants.
Does a flagged result on a remote screening tool mean a diagnosis?
No. Tools like ORCA-PD are designed to separate patients who may need further evaluation from those who don't, which typically leads to additional testing rather than an immediate diagnosis.
Will remote testing replace in-person visits entirely in Parkinson's studies?
Not necessarily. Some studies, like COPE-PAP, substituted phone testing for specific follow-up visits while keeping other assessments in person, so ask which visits in your study are affected.
You Might Also Like
- What a Parkinson’s Caregiver Should Know Before a Study Visit Schedule
- What Happens During Screening for a Deep Brain Stimulation Trial?
- Parkinson’s Dementia Studies and the Challenge of Recruiting Beyond Specialist Centers